Cargando…
Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy
Background: Telomerase (human telomerase reverse transcriptase (hTERT) is considered a hallmark of cancer, being active in cancer cells but repressed in human somatic cells. As such, it has the potential to serve as a valid cancer biomarker. Exosomal hTERT mRNA can be detected in the serum of patien...
Autores principales: | Rotem, Ofer, Zer, Alona, Yosef, Lilach, Beery, Einat, Goldvaser, Hadar, Gutkin, Anna, Levin, Ron, Dudnik, Elizabeth, Berger, Tamar, Feinmesser, Meora, Levy-Barda, Adva, Lahav, Meir, Raanani, Pia, Uziel, Orit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295971/ https://www.ncbi.nlm.nih.gov/pubmed/37371825 http://dx.doi.org/10.3390/biomedicines11061730 |
Ejemplares similares
-
Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells
por: Gutkin, Anna, et al.
Publicado: (2016) -
Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker
por: Goldvaser, Hadar, et al.
Publicado: (2017) -
Characterization of blood-derived exosomal hTERT mRNA as a biomarker for colon cancer and Lynch syndrome
por: Laish, Ido, et al.
Publicado: (2022) -
The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells
por: Shalem-Cohavi, Naama, et al.
Publicado: (2019) -
The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma
por: Uziel, Orit, et al.
Publicado: (2014)